TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 91 filers reported holding TG THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 117.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,599,000 | -42.2% | 399,949 | +1.3% | 1.14% | +4.7% |
| Q3 2021 | $13,144,000 | -18.3% | 394,949 | -4.8% | 1.09% | -16.1% |
| Q2 2021 | $16,096,000 | -35.0% | 414,949 | -19.2% | 1.30% | -30.6% |
| Q1 2021 | $24,758,000 | +130.4% | 513,649 | +148.7% | 1.88% | +148.0% |
| Q4 2020 | $10,745,000 | +803.7% | 206,549 | +105.8% | 0.76% | +394.8% |
| Q3 2017 | $1,189,000 | +45.5% | 100,366 | +23.5% | 0.15% | +71.9% |
| Q2 2017 | $817,000 | -49.0% | 81,266 | -40.9% | 0.09% | -52.4% |
| Q1 2017 | $1,602,000 | -87.6% | 137,500 | -91.0% | 0.19% | -70.2% |
| Q1 2016 | $12,965,000 | -28.6% | 1,521,667 | 0.0% | 0.63% | -19.0% |
| Q4 2015 | $18,153,000 | +23.0% | 1,521,667 | +3.9% | 0.77% | +14.5% |
| Q3 2015 | $14,758,000 | +15.2% | 1,464,105 | +89.6% | 0.68% | +26.6% |
| Q2 2015 | $12,808,000 | +89.7% | 772,017 | +77.0% | 0.53% | +108.6% |
| Q1 2015 | $6,751,000 | – | 436,084 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |